Karikó K - Search Results

1

Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses.

Alameh MG, Tombácz I, Bettini E, Lederer K, Sittplangkoon C, Wilmore JR, Gaudette BT, Soliman OY, Pine M, Hicks P, Manzoni TB, Knox JJ, Johnson JL, Laczkó D, Muramatsu H, Davis B, Meng W, Rosenfeld AM, Strohmeier S, Lin PJC, Mui BL, Tam YK, Karikó K, Jacquet A, Krammer F, Bates P, Cancro MP, Weissman D, Luning Prak ET, Allman D, Locci M, Pardi N. Alameh MG, et al. Among authors: kariko k. Immunity. 2022 Jun 14;55(6):1136-1138. doi: 10.1016/j.immuni.2022.05.007. Immunity. 2022. PMID: 35704995 Free PMC article. No abstract available.

2

Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA.

Karikó K, Buckstein M, Ni H, Weissman D. Karikó K, et al. Immunity. 2005 Aug;23(2):165-75. doi: 10.1016/j.immuni.2005.06.008. Immunity. 2005. PMID: 16111635 Free article.

3

Naturally occurring nucleoside modifications suppress the immunostimulatory activity of RNA: implication for therapeutic RNA development.

Karikó K, Weissman D. Karikó K, et al. Curr Opin Drug Discov Devel. 2007 Sep;10(5):523-32. Curr Opin Drug Discov Devel. 2007. PMID: 17786850 Review.

4

Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA.

Karikó K, Muramatsu H, Ludwig J, Weissman D. Karikó K, et al. Nucleic Acids Res. 2011 Nov;39(21):e142. doi: 10.1093/nar/gkr695. Epub 2011 Sep 2. Nucleic Acids Res. 2011. PMID: 21890902 Free PMC article.

5

Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietin.

Karikó K, Muramatsu H, Keller JM, Weissman D. Karikó K, et al. Mol Ther. 2012 May;20(5):948-53. doi: 10.1038/mt.2012.7. Epub 2012 Feb 14. Mol Ther. 2012. PMID: 22334017 Free PMC article.

6

In vitro transcription of long RNA containing modified nucleosides.

Pardi N, Muramatsu H, Weissman D, Karikó K. Pardi N, et al. Among authors: kariko k. Methods Mol Biol. 2013;969:29-42. doi: 10.1007/978-1-62703-260-5_2. Methods Mol Biol. 2013. PMID: 23296925 Review.

7

HPLC purification of in vitro transcribed long RNA.

Weissman D, Pardi N, Muramatsu H, Karikó K. Weissman D, et al. Among authors: kariko k. Methods Mol Biol. 2013;969:43-54. doi: 10.1007/978-1-62703-260-5_3. Methods Mol Biol. 2013. PMID: 23296926

8

Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes.

Pardi N, Tuyishime S, Muramatsu H, Kariko K, Mui BL, Tam YK, Madden TD, Hope MJ, Weissman D. Pardi N, et al. Among authors: kariko k. J Control Release. 2015 Nov 10;217:345-51. doi: 10.1016/j.jconrel.2015.08.007. Epub 2015 Aug 8. J Control Release. 2015. PMID: 26264835 Free PMC article.

9

mRNA: Fulfilling the Promise of Gene Therapy.

Weissman D, Karikó K. Weissman D, et al. Among authors: kariko k. Mol Ther. 2015 Sep;23(9):1416-7. doi: 10.1038/mt.2015.138. Mol Ther. 2015. PMID: 26321183 Free PMC article. No abstract available.

10

Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge.

Pardi N, Secreto AJ, Shan X, Debonera F, Glover J, Yi Y, Muramatsu H, Ni H, Mui BL, Tam YK, Shaheen F, Collman RG, Karikó K, Danet-Desnoyers GA, Madden TD, Hope MJ, Weissman D. Pardi N, et al. Among authors: kariko k. Nat Commun. 2017 Mar 2;8:14630. doi: 10.1038/ncomms14630. Nat Commun. 2017. PMID: 28251988 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

102 results

Search Page